Medical Forum / General / Nutrition / May 2005
Not too little omega 3s, but too much omega 6s.
|
|
Thread rating:  |
montygram - 28 May 2005 23:48 GMT Here's just another example of what I've been saying here for years now. At least these researchers are honest enough to admit what their experiment revealed, unlike so many others who begin with assumptions about how very dangerous fatty acids are "essential" to humans when one rat experiment was done in 1929/30 (Burr & Burr), before all essential nutrients, such as some of the B vitamins, were known, and thus any experiment done at that time would have to be done again with all the known nutrients, controlling for what is being tested for essentiality (plus, dogs would be better than rats for this experiment - much closer to humans in terms of fatty acid metabolization).
Source: www.sciencedaily.com 5/25/2005 Study Links Brain Fatty Acid Levels To Depression
Bethesda, MD -- A group of researchers from Israel has discovered that rats exhibiting the signs of depression have increased levels of the omega-6 fatty acid, arachidonic acid, in their brains. The details of their findings appear in the June issue of the Journal of Lipid Research, an American Society for Biochemistry and Molecular Biology journal.
During recent years, omega-3 fatty acids have enjoyed increased popularity as numerous studies have shown that supplementing diets with fish oil (a natural source of this polyunsaturated fatty acid) does everything from reducing the risk of heart disease to preventing arthritis. There is also evidence that depression may be associated with a dietary deficiency in omega-3 fatty acids. This "phospholipid hypothesis" of depression has been supported by research showing that omega-3 fatty acid concentration in the blood of depressed patients is lower than that in control patients.
"The "phospholipid hypothesis" of depression postulates that decreased omega-3 fatty acid intake, and hence, perhaps decreased brain omega-3 fatty acid content, could be responsible for the disease," explains Dr. Pnina Green of Tel Aviv University. "In humans, because of high dietary variability and the obvious inability to examine brain tissue, the theory is backed up mainly by indirect evidence. The availability of the Flinders Sensitive Line rat, an animal model of depression, overcomes both these obstacles."
In the Journal of Lipid Research study, Dr. Green in collaboration with Dr Gal Yadid of Bar-Ilan University, Ramat Gan, used the Flinders Sensitive Line rats to investigate the link between omega-3 fatty acids and depression. They examined the brains of the depressed rats and compared them with brains from normal rats. Surprisingly, they found that the main difference between the two types of rats was in omega-6 fatty acid levels and not omega-3 fatty acid levels. Specifically, they discovered that brains from rats with depression had higher concentrations of arachidonic acid, a long-chain unsaturated metabolite of omega-6 fatty acid.
Arachidonic acid is found throughout the body and is essential for the proper functioning of almost every body organ, including the brain. It serves a wide variety of purposes, from being a purely structural element in phospholipids to being involved in signal transduction and being a substrate for a host of derivatives involved in second messenger function.
"The finding that in the depressive rats the omega-3 fatty acid levels were not decreased, but arachidonic acid was substantially increased as compared to controls is somewhat unexpected," admits Dr. Green. "But the finding lends itself nicely to the theory that increased omega-3 fatty acid intake may shift the balance between the two fatty acid families in the brain, since it has been demonstrated in animal studies that increased omega-3 fatty acid intake may result in decreased brain arachidonic acid."
Although far less attention has been paid to dietary requirements for omega-6 fatty acids, which can be found in most edible oils and meat, perhaps in the future depression may be controlled by increasing omega-3 fatty acid intake and decreasing omega-6 fatty acid intake.
Sbharris[atsign]ix.netcom.com - 29 May 2005 04:08 GMT >>Here's just another example of what I've been saying here for years now. At least these researchers are honest enough to admit what their experiment revealed, unlike so many others who begin with assumptions about how very dangerous fatty acids are "essential" to humans when one
rat experiment was done in 1929/30 (Burr & Burr), before all essential nutrients, such as some of the B vitamins, were known, and thus any experiment done at that time would have to be done again with all the known nutrients, controlling for what is being tested for essentiality (plus, dogs would be better than rats for this experiment - much closer
to humans in terms of fatty acid metabolization). <<
COMMENT:
A lot of experimental evidence has demonstrated the need of n-3 and n-6 EFAs in the diet of both young and old mammals since 1930. You seem to be having difficulty either finding it or retaining it. Perhaps a shortage of n-3 in your own brain?
SBH
Sbharris[atsign]ix.netcom.com - 29 May 2005 04:10 GMT Br J Nutr. 2000 Dec;84(6):803-12.
The conditional nature of the dietary need for polyunsaturates: a proposal to reclassify 'essential fatty acids' as 'conditionally-indispensable' or 'conditionally-dispensable' fatty acids.
Cunnane SC.
Department of Nutritional Sciences, Faculty of Medicine, University of Toronto, Canada. cunnane@utoronto.ca.
The term essential fatty acid no longer clearly identifies the fatty acids it was originally used to describe. It would be more informative if the concept of essentiality shifted away from the symptoms arising from the lack of de novo synthesis of linoleate or alpha-linolenate and towards the adequacy of the capacity for synthesis and conservation of both the parent and the derived long-chain polyunsaturates. For instance, despite the existence of the pathway for synthesis of docosahexaenoate from alpha-linolenate, the former would be more correctly classified as 'conditionally indispensable' because the capacity of the pathway appears insufficient during early development, although it may be sufficient later in life in healthy individuals. Similarly, despite the inability to synthesize linoleate de novo, abundant linoleate stores and its relatively slow turnover in healthy adults probably makes linoleate 'conditionally dispensable' for long periods. There are two other anomalies with the terms essential and non-essential fatty acids: (1) under several different experimental circumstances, the C-skeleton of essential fatty acids is avidly used in the synthesis of non-essential fatty acids; (2) to function normally, the brain is required to endogenously synthesize several non-essential fatty acids. As with essential amino acids, which have been reclassified as indispensable or conditionally indispensable, such a change in terminology should lead to an improved understanding of the function and metabolism of polyunsaturates in particular, and long-chain fatty acids in general.
Publication Types: Review Review, Tutorial
PMID: 11177196 [PubMed - indexed for MEDLINE]
J Nutr Health Aging. 2004;8(3):163-74.
Roles of unsaturated fatty acids (especially omega-3 fatty acids) in the brain at various ages and during ageing.
Bourre JM.
INSERM Research Director. Unit U26 Neuro-pharmaco-nutrition. Hopital Fernand Widal, 200 rue du Faubourg Saint Denis. 75745 Paris cedex 10. jean-marie.bourre@fwidal.inserm.fr
Among various organs, in the brain, the fatty acids most extensively studied are omega-3 fatty acids. Alpha-linolenic acid (18:3omega3) deficiency alters the structure and function of membranes and induces minor cerebral dysfunctions, as demonstrated in animal models and subsequently in human infants. Even though the brain is materially an organ like any other, that is to say elaborated from substances present in the diet (sometimes exclusively), for long it was not accepted that food can have an influence on brain structure, and thus on its function. Lipids, and especially omega-3 fatty acids, provided the first coherent experimental demonstration of the effect of diet (nutrients) on the structure and function of the brain. In fact the brain, after adipose tissue, is the organ richest in lipids, whose only role is to participate in membrane structure. First it was shown that the differentiation and functioning of cultured brain cells requires not only alpha-linolenic acid (the major component of the omega-3, omega3 family), but also the very long omega-3 and omega-6 carbon chains (1). It was then demonstrated that alpha-linolenic acid deficiency alters the course of brain development, perturbs the composition and physicochemical properties of brain cell membranes, neurones, oligodendrocytes, and astrocytes (2).This leads to physicochemical modifications, induces biochemical and physiological perturbations, and results in neurosensory and behavioural upset (3). Consequently, the nature of polyunsaturated fatty acids (in particular omega-3) present in formula milks for infants (premature and term) conditions the visual and cerebral abilities, including intellectual. Moreover, dietary omega-3 fatty acids are certainly involved in the prevention of some aspects of cardiovascular disease (including at the level of cerebral vascularization), and in some neuropsychiatric disorders, particularly depression, as well as in dementia, notably Alzheimer's disease. Recent results have shown that dietary alpha-linolenic acid deficiency induces more marked abnormalities in certain cerebral structures than in others, as the frontal cortex and pituitary gland are more severely affected. These selective lesions are accompanied by behavioural disorders more particularly affecting certain tests (habituation, adaptation to new situations). Biochemical and behavioural abnormalities are partially reversed by a dietary phospholipid supplement, especially omega-3-rich egg yolk extracts or pig brain. A dose-effect study showed that animal phospholipids are more effective than plant phospholipids to reverse the consequences of alpha-linolenic acid deficiency, partly because they provide very long preformed chains. Alpha-linolenic acid deficiency decreases the perception of pleasure, by slightly altering the efficacy of sensory organs and by affecting certain cerebral structures. Age-related impairment of hearing, vision and smell is due to both decreased efficacy of the parts of the brain concerned and disorders of sensory receptors, particularly of the inner ear or retina. For example, a given level of perception of a sweet taste requires a larger quantity of sugar in subjects with alpha-linolenic acid deficiency. In view of occidental eating habits, as omega-6 fatty acid deficiency has never been observed, its impact on the brain has not been studied. In contrast, omega-9 fatty acid deficiency, specifically oleic acid deficiency, induces a reduction of this fatty acid in many tissues, except the brain (but the sciatic nerve is affected). This fatty acid is therefore not synthesized in sufficient quantities, at least during pregnancy-lactation, implying a need for dietary intake. It must be remembered that organization of the neurons is almost complete several weeks before birth, and that these neurons remain for the subject's life time. Consequently, any disturbance of these neurons, an alteration of their connections, and impaired turnover of their constituents at any stage of life, will tend to accelerate ageing. The enzymatic activities of sytivities of synthesis of long-chain polyunsaturated fatty acids from linoleic and alpha-linolenic acids are very limited in the brain: this organ therefore depends on an exogenous supply. Consequently, fatty acids that are essential for the brain are arachidonic acid and cervonic acid, derived from the diet, unless they are synthesized by the liver from linoleic acid and alpha-linolenic acid. The age-related reduction of hepatic desaturase activities (which participate in the synthesis of long chains, together with elongases) can impair turnover of cerebral membranes. In many structures, especially in the frontal cortex, a reduction of cervonic and arachidonic acids is observed during ageing, predominantly associated with a reduction of phosphatidylethanolamines (mainly in the form of plasmalogens). Peroxisomal oxidation of polyunsaturated fatty acids decreases in the brain during ageing, participating in decreased turnover of membrane fatty acids, which are also less effectively protected against peroxidation by free radicals.
Publication Types: Review Review, Tutorial
PMID: 15129302 [PubMed - indexed for MEDLINE]
J Nutr. 1998 Feb;128(2 Suppl):427S-433S.
Comment in: J Nutr. 1999 Feb;129(2):446.
The slow discovery of the importance of omega 3 essential fatty acids in human health.
Holman RT.
Hormel Institute, University of Minnesota, Austin 55912, USA.
Although linoleic and linolenic acids have been known to be necessary for normal growth and dermal function since 1930, the omega 3 essential fatty acids (EFA) have not received much attention until recently. The two families of acids are metabolized by the same enzymes, making them competitive. Gross deficiencies of omega 6 plus omega 3 EFA have been observed in humans, induced by attempts at total parenteral nutrition (TPN) with preparations devoid of lipids. Deficiency of omega 3 acids has been induced by TPN containing high omega 6 and low omega 3 fatty acids. In natural human populations, a wide range of omega 3 and omega 6 proportions have been found, ranging from high omega 3 and low omega 6 content to low omega 3 and high omega 6 content, showing inverse correlation between sigma omega 6 and sigma omega 3. In humans with neuropathy or impairment of the immune system, significant deficits of omega 3 EFA have been measured.
Publication Types: Review Review, Tutorial
PMID: 9478042 [PubMed - indexed for MEDLINE]
Curr Opin Clin Nutr Metab Care. 2002 Mar;5(2):127-32.
Efficiency of conversion of alpha-linolenic acid to long chain n-3 fatty acids in man.
Brenna JT.
Division of Nutritional Sciences, Savage Hall, Cornell University, Ithaca, New York 14853, USA. jtb4@cornell.edu
Alpha-linolenic acid (18:3n-3) is the major n-3 (omega 3) fatty acid in the human diet. It is derived mainly from terrestrial plant consumption and it has long been thought that its major biochemical role is as the principal precursor for long chain polyunsaturated fatty acids, of which eicosapentaenoic (20:5n-3) and docosahexaenoic acid (22:6n-3) are the most prevalent. For infants, n-3 long chain polyunsaturated fatty acids are required for rapid growth of neural tissue in the perinatal period and a nutritional supply is particularly important for development of premature infants. For adults, n-3 long chain polyunsaturated fatty acid supplementation is implicated in improving a wide range of clinical pathologies involving cardiac, kidney, and neural tissues. Studies generally agree that whole body conversion of 18:3n-3 to 22:6n-3 is below 5% in humans, and depends on the concentration of n-6 fatty acids and long chain polyunsaturated fatty acids in the diet. Complete oxidation of dietary 18:3n-3 to CO2 accounts for about 25% of 18:3n-3 in the first 24 h, reaching 60% by 7 days. Much of the remaining 18:3n-3 serves as a source of acetate for synthesis of saturates and monounsaturates, with very little stored as 18:3n-3. In term and preterm infants, studies show wide variability in the plasma kinetics of 13C n-3 long chain polyunsaturated fatty acids after 13C-18:3n-3 dosing, suggesting wide variability among human infants in the development of biosynthetic capability to convert 18:3n-3 to 22:6n3. Tracer studies show that humans of all ages can perform the conversion of 18:3n-3 to 22:6n3. Further studies are required to establish quantitatively the partitioning of dietary 18:3n-3 among metabolic pathways and the influence of other dietary components and of physiological states on these processes.
Publication Types: Review Review, Tutorial
PMID: 11844977 [PubMed - indexed for MEDLINE]
Annu Rev Nutr. 2004;24:597-615.
Dietary n-6 and n-3 fatty acid balance and cardiovascular health.
Wijendran V, Hayes KC.
Foster Biomedical Research Lab, Brandeis University, Waltham, Massachusetts 02254, USA. vwijen@brandeis.edu
Epidemiological and clinical studies have established that the n-6 fatty acid, linoleic acid (LA), and the n-3 fatty acids, linolenic acid (LNA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA) collectively protect against coronary heart disease (CHD). LA is the major dietary fatty acid regulating low-density lipoprotein (LDL)-C metabolism by downregulating LDL-C production and enhancing its clearance. Further, the available mass of LA is a critical factor determining the hyperlipemic effects of other dietary fat components, such as saturated and trans fatty acids, as well as cholesterol. By contrast, n-3 fatty acids, especially EPA and DHA, are potent antiarryhthmic agents. EPA and DHA also improve vascular endothelial function and help lower blood pressure, platelet sensitivity, and the serum triglyceride level. The distinct functions of these two families make the balance between dietary n-6 and n-3 fatty acids an important consideration influencing cardiovascular health. Based on published literature describing practical dietary intakes, we suggest that consumption of ~6% en LA, 0.75% en LNA, and 0.25% en EPA + DHA represents adequate and achievable intakes for most healthy adults. This corresponds to an n-6/n-3 ratio of ~6:1. However, the absolute mass of essential fatty acids consumed, rather than their n-6/n-3 ratio, should be the first consideration when contemplating lifelong dietary habits affecting cardiovascular benefit from their intake.
Publication Types: Review
PMID: 15189133 [PubMed - indexed for MEDLINE]
montygram - 30 May 2005 20:47 GMT Are you trying to prove my point with these "studies?" They do exactly what I have been pointing out here for years, that is: they mention the 1930 study, but fail to mention that not all essential nutrients were known - thus there is no way such a study could be anything but worthy of a follow-up, which nobody has ever done. I have proposed such an experiment, on dogs (a better animal model than the 1930 rat experiment), but have had no takers to my offer (to sum it up: if the adult animals consuming only trace amounts of omega 3 and 6 PUFAs live at least as long as the ones consuming supposedly adequate amounts, you pay, but if they live a statistically significant less amount of time, then I'll pay for it - same diet otherwise for both groups of dogs). They say they've done an experiment on brain cells - did they use the alternative PUFA, the omega 9 Mead acid? No, of course not, that would mean actually doing something scientifically valid.
And, of course, none of this means that adults need omega 3s or 6s. They say omega 3s are needed for immune function, but it's been demonstrated over and over again that omega 3s are highly immunosuppressive. It's the ability to counteract the incredibly dangerous omega 6, arachidonic acid, that is being demonstrated in such experiments, not a "need" for them. They fail to mention anything about people like my grandparents, who are mid 80s - early 90s, and never had anything beyond a few molecules of omega 3s all their lives (they don't eat canola oil, flax, fish, DHA enhanced eggs, etc.), but are in pretty good shape, probably because of the chocolate and coffee they consume. They also don't talk about how Eskimos on diets high in omega 3s died so young, usually around the age of 40, due to the effects of these fatty acids (bleeding strokes, death from internal bleeding due to minor traumas, shock from minor traumas, etc.).
The bottom line: no experiment that is directly on point, even in an animal model, has been done to demonstrate that omega 3s and 6s, in any amount, are required for adult humans (in the way that vitamin B12 is, for example), and there are thousands, if not tens of thousands, of studies that demonstrate how dangerous these highly unstable molecules are. There is no doubt about this - it is the scientific reality. All the studies you can cite that supposedly claim "essentiality" do nothing of the sort, unless you are doing something other than science, perhaps creating a religion in which particular PUFAs are worshipped as divine in some way.
mattlb@angelfire.com - 31 May 2005 18:08 GMT > Are you trying to prove my point with these "studies?" They do > exactly what I have been pointing out here for years, that is: they [quoted text clipped - 20 lines] > about people like my grandparents, who are mid 80s - early 90s, and > never had anything beyond a few molecules of omega 3s all their lives Your rigid scientific method cracks me up.
> (they don't eat canola oil, flax, fish, DHA enhanced eggs, etc.), but > are in pretty good shape, probably because of the chocolate and coffee > they consume. You've got to be trolling.
> They also don't talk about how Eskimos on diets high > in omega 3s died so young, usually around the age of 40, due to the > effects of these fatty acids (bleeding strokes, death from internal > bleeding due to minor traumas, shock from minor traumas, etc.). Arachidonic acid deficiency, you think?
> The bottom line: no experiment that is directly on point, even in an > animal model, has been done to demonstrate that omega 3s and 6s, in any > amount, are required for adult humans (in the way that vitamin B12 is, > for example), You're obvious desperate to be the group clown. In the post BY YOU that started this thread it has:
"Arachidonic acid is found throughout the body and is essential for the proper functioning of almost every body organ, including the brain. It serves a wide variety of purposes, from being a purely structural element in phospholipids to being involved in signal transduction and being a substrate for a host of derivatives involved in second messenger function."
Are we to take it you don't believe your own hype?
> and there are thousands, if not tens of thousands, of > studies that demonstrate how dangerous these highly unstable molecules > are. There is no doubt about this - it is the scientific reality. > All the studies you can cite that supposedly claim "essentiality" > do nothing of the sort, Ho hum. Here's outing number five for this...
"Thirty years later, Hansen et al. [140] were the first to describe EFAD in humans. They observed unsatisfactory growth rates and dryness of the skin in many infants on low LA intakes. EFAD has been most extensively described in subjects on fat-free total parenteral nutrition (TPN)[141-147]. For example, O'Neill et al. [142] reported on 28 patients,ranging from newborns to 66 years old, who received fat-free TPN. LA levels fell rapidly, followed by AA. In most of the patients the 20:3n9/20:4n6 ratio (a biochemical marker for EFAD) had increased after a few weeks above the 0.4 criterion [148], followed approximately one week later by clinical signs of a scaly and thin skin, and hair loss. In addition to these classical EFAD symptoms, many other biological and behavioural changes have been documented [149-151]"
Two of the refs:
Wene JD, Connor WE, DenBesten L. The development of essential fatty acid deficiency in healthy men fed fat-free diets intravenously and orally. J Clin Invest 1975;56:127-34
O'Neill JA, Caldwell MD, Meng HC. Essential fatty acid deficiency in surgical patients. Ann Surg 1977;185:535-41"
As predicted you didn't respond to this one about fatty acid deficiency in dogs that Steve Harris pointed out to you either:
Here's the PubMed link http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstra ct&list_uids=1263442
> unless you are doing something other than > science, perhaps creating a religion in which particular PUFAs are > worshipped as divine in some way. Like Mead Acid you mean?
MattLB
MMu - 30 May 2005 11:51 GMT > Here's just another example of what I've been saying here for years > now. What "you have been saying here for years" is ever so slightly changing.. once it was: all PUFA's are the ultimate evil.. now you slowly seem to adapt to the idea that w3's can actually be beneficial.
>At least these researchers are honest enough to admit what their > experiment revealed, unlike so many others who begin with assumptions [quoted text clipped - 5 lines] > (plus, dogs would be better than rats for this experiment - much closer > to humans in terms of fatty acid metabolization). Sbharris commented on this 1930's myth already. You seem to like this idea quite a lot since you still cite yourself on that constantly.. you are not up to date on the literature there.
> Source: www.sciencedaily.com > 5/25/2005 [quoted text clipped - 57 lines] > perhaps in the future depression may be controlled by increasing > omega-3 fatty acid intake and decreasing omega-6 fatty acid intake. montygram - 30 May 2005 20:53 GMT No, I stay away from omega 3s, but I am only interested in the scientific reality, and it is clear that if you are loaded up with arachidonic acid, and getting destroyed by AA metabolites, then the omega 3s will knock down the metabolization to some degree. It is a temporary fix, and I have cited studies that point out that after a certain period of time, the omega 3 group actually has more problems than the control group.
As for Burr & Burr: that is what is cited in the major nutrition textbooks, and yet even on the level of logic, it is unjustifiable to suggest that this rat experiment done in 1930 "proves" anything. We need to do that experiment again with proper controls. Now if you know of such an experiment, then go ahead and cite it. Until then, all one can say as a scientist is that there is a huge amount of evidence against consuming more than tiny amounts of omega 3s and 6s, and no scientific evidence suggesting that it is "essential" in a way that non-pregnant human adults should worry about getting more of it. Instead, at this point in time, the reasonable person with some scientific knowledge knows that avoiding these dangerous substances is consistent with the evidence.
|
|
|